CD4 and amyloidosis: Indeed, administration of Aβ-specific type 1 (TH1) and type 17 (TH17) CD4+ T cells (two specialized populations of CD4+ T cells characterized by specific secretory profiles) reportedly exacerbates memory impairment and amyloid deposition in APP-PS1 mice84.